医学
重症监护医学
肝性脑病
脑病
病理生理学
微生物群
内科学
生物信息学
肝硬化
生物
作者
Ariel Jaffe,Joseph K. Lim,Simona Jakab
标识
DOI:10.1016/j.cld.2020.01.002
摘要
Hepatic encephalopathy (HE) is one of the major clinical decompensations of cirrhosis, with a high impact on health care resource utilization and cost. For an effective and comprehensive management of HE, the clinicians need to understand the pathophysiologic mechanisms of HE. This review describes the multiorgan processes involved in HE and how several HE precipitants and treatment strategies act on ammonia production, excretion, and neurotoxicity, including the impact of diabetes and use of cannabinoids. The authors also discuss the current and future role of gut microbiome, systemic/central inflammation, and various neurotransmitters for the pathogenesis and treatment of HE.
科研通智能强力驱动
Strongly Powered by AbleSci AI